SECreport

Form 4 BIOTIME INC For: Jul 01 Filed by: FARRELL STEPHEN C

Brooklyn ImmunoTherapeutics, Inc.  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors